French IVD (In Vitro Diagnostics) sales growth slows
This article was originally published in Clinica
Executive Summary
The increase in the French market for in vitro diagnostics slowed to approximately 2.4% in 2000, just half of the 4.8% rise seen in 1999, according to early estimates. Precise figures have not yet been released and will be reported by Clinica next month. The French association representing manufacturers of clinical analyses, SFRL, blames economic disincentives for doctors to prescribe medical tests as the reason behind the current deceleration of the market's growth.